Antifungal phenylethylene
First Claim
1. A method of treating a host afflicted by a fungi (this includes yeast and filamentous forms) by administering an effective amount of 1-(3′
- ,4,′
5′
-trimethoxyphenyl)-2-nitro-ethylene thereto.
4 Assignments
0 Petitions
Accused Products
Abstract
The antifungal and cancer cell growth inhibitory activities of 1-(3′,4′,5′-trimethoxyphenyl)-2-nitro-ethylene (TMPN) were examined. TMPN was fungicidal for the majority of 132 reference strains and clinical isolates tested, including those resistant to fluconazole, ketoconazole, amphotericin B or flucytosine. Minimum fungicidal concentration/minimum inhibitory concentration (MFC/MIC) ratios were ≦2 for 96% of Cryptococcus neoformans clinical isolates and 71% of Candida albicans clinical isolates. TMPN was fungicidal for a variety of other basidiomycetes, endomycetes and hyphomycetes, and its activity was unaffected by alterations in media pH. TMPN was slightly cytotoxic for murine and human cancer cell lines (GI50=1-4 μg/ml), and weakly inhibited mammalian tubulin polymerization (IC50=0.60 μg/ml). TMPN may also be used as a biochemical probe for tubulin and fungal dimorphism studies.
22 Citations
5 Claims
-
1. A method of treating a host afflicted by a fungi (this includes yeast and filamentous forms) by administering an effective amount of 1-(3′
- ,4,′
5′
-trimethoxyphenyl)-2-nitro-ethylene thereto. - View Dependent Claims (2, 3)
- ,4,′
-
4. A method of using an effective amount of 1-(3′
- ,4,′
5′
-trimethoxyphenyl)-2-nitro-ethylene as a biochemical probe. - View Dependent Claims (5)
- ,4,′
Specification